MannKind to Present at the Morgan Stanley Healthcare Conference

VALENCIA, Calif., April 28 MannKind Corporation(Nasdaq: MNKD), focused on discovering, developing and commercializingtreatments for diabetes and cancer, announced today that it will present atthe Morgan Stanley Healthcare Conference on Wednesday, April 30, 2008 at 8:30AM ET at The Ritz-Carlton, Key Biscayne, Florida.

Interested parties can access a link to the live web cast of thepresentation in the Investor Relations section of the Company's website atwww.mannkindcorp.com. A replay of each presentation will be available for 14days.

About MannKind Corporation

MannKind Corporation (Nasdaq: MNKD) focuses on the discovery, developmentand commercialization of therapeutic products for diseases such as diabetesand cancer. Its lead product, the Technosphere(R) Insulin System, iscurrently in phase 3 clinical trials in the United States, Europe and LatinAmerica to study its safety and efficacy in the treatment of diabetes. Formore information on MannKind Corporation and its technology, visitwww.mannkindcorp.com.

SOURCE MannKind Corporation

Latest Press Release on General News

Precision oncology company Flindr Therapeutics announces €20 million Series A financing to advance first-in-class small molecule inhibitors

V-Bio Ventures leads international syndicate which includes Johnson & Johnson Innovation – JJDC, Inc., QBIC Fund, Flanders Future Tech Fund, Curie Capital as well as seed investor...

Rett Syndrome Research Trust Partners with Vivalink to Shift Symptom Assessment Paradigms in Rett Syndrome

Vivalink's remote patient monitoring solutions accelerate research into rare neurological disorder CAMPBELL, Calif. , April 23, 2024 /PRNewswire/ -- Vivalink , a leading pro...

World IBS Day - April 19th: Raising Awareness for Everyone with IBS

Debunking myths about Irritable Bowel Syndrome TORONTO , April 18, 2024 /PRNewswire/ -- IBS is a chronic gastrointestinal disorder with symptoms like abdominal pain, bloating,...

Important step taken on the Canada Disability Benefit in Budget 2024, but funding falls short

More work must be done to lift Canadians with disabilities out of poverty TORONTO , April 17, 2024 /CNW/ - The federal government has taken an important step on the Canada Di...

Hydrinity Accelerated Skin Science Introduces MicroFusion Technology and Expands Facial Skincare Line with PRELUDE Facial Treatment Cleanser and HYDRI-C Vitamin C Moisturizer

The Next Generation Technology with the Power to Transform Skin MONROE, La. , April 15, 2024 /PRNewswire/ -- Hydrinity Accelerated Skin Science announced today the launch of t...